Antagonist

Results: 956



#Item
351Microsoft PowerPoint - full.ppt

Microsoft PowerPoint - full.ppt

Add to Reading List

Source URL: www.accp1.org

Language: English - Date: 2011-03-25 17:31:30
352XXXXXXX  EMEND® (aprepitant) CAPSULES DESCRIPTION

XXXXXXX EMEND® (aprepitant) CAPSULES DESCRIPTION

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 14:51:10
353sPeCiAl ArTiCle  Canadian Association of Gastroenterology Clinical Practice Guidelines: The use of tumour necrosis factor-alpha antagonist therapy in Crohn’s disease Daniel C Sadowski MD1, Charles N Bernstein MD2, Alai

sPeCiAl ArTiCle Canadian Association of Gastroenterology Clinical Practice Guidelines: The use of tumour necrosis factor-alpha antagonist therapy in Crohn’s disease Daniel C Sadowski MD1, Charles N Bernstein MD2, Alai

Add to Reading List

Source URL: www.cag-acg.org

Language: English - Date: 2011-05-26 17:34:53
354Microsoft Word - Kansas Hypertension Outcomes.doc

Microsoft Word - Kansas Hypertension Outcomes.doc

Add to Reading List

Source URL: www.kdheks.gov

Language: English - Date: 2012-02-06 11:16:09
355Kappa Opioid Receptor Agonists and Antagonist Summary: The present invention is an entirely new chemotype of KOR weak partial agonists. Contact Information: Matt Koenig, J.D. KU Innovation & Collaboration[removed]m

Kappa Opioid Receptor Agonists and Antagonist Summary: The present invention is an entirely new chemotype of KOR weak partial agonists. Contact Information: Matt Koenig, J.D. KU Innovation & Collaboration[removed]m

Add to Reading List

Source URL: kuic.ku.edu

Language: English - Date: 2014-01-30 10:26:50
356Novel Methods for Antagonizing Kappa Opioid Receptors Summary: The invention is a method for antagonizing kappa opioid receptors (KOR) present in tissue in vitro or in vivo. Contact Information: Aswini K. Betha, Ph.D. KU

Novel Methods for Antagonizing Kappa Opioid Receptors Summary: The invention is a method for antagonizing kappa opioid receptors (KOR) present in tissue in vitro or in vivo. Contact Information: Aswini K. Betha, Ph.D. KU

Add to Reading List

Source URL: kuic.ku.edu

Language: English - Date: 2014-01-30 10:23:55
357Design of an Agonist-Antagonist Active Knee Prosthesis

Design of an Agonist-Antagonist Active Knee Prosthesis

Add to Reading List

Source URL: biomech.media.mit.edu

Language: English - Date: 2013-06-20 17:54:31
358TAKE HOME NALOXONE: KEY POINTS FOR MEDICAL, ETHICAL AND LEGAL CONCERNS Naloxone is a medication that saves lives by reversing the effects of an overdose from opioids (e.g. heroin, methadone, morphine). BC’s Take Home N

TAKE HOME NALOXONE: KEY POINTS FOR MEDICAL, ETHICAL AND LEGAL CONCERNS Naloxone is a medication that saves lives by reversing the effects of an overdose from opioids (e.g. heroin, methadone, morphine). BC’s Take Home N

Add to Reading List

Source URL: towardtheheart.com

Language: English - Date: 2014-11-21 20:00:26
359Workloop Energetics of Antagonist Muscles

Workloop Energetics of Antagonist Muscles

Add to Reading List

Source URL: biomech.media.mit.edu

Language: English - Date: 2013-07-10 18:28:47
360Microsoft Word - KS Diabetes Outcomes.doc

Microsoft Word - KS Diabetes Outcomes.doc

Add to Reading List

Source URL: www.kdheks.gov

Language: English - Date: 2012-02-06 11:16:00